Cargando…

A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model

We earlier found that a rat monoclonal antibody (mAb) RE2 can induce rapid death of murine activated, but not resting, lymphocytes and lymphocyte cell lines, in a complement-independent manner, a cell death differing from typical apoptosis or necrosis. We here found that this cell death is independe...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Shuji, Tsurui, Hiromichi, Abe, Masaaki, Terashima, Kazuo, Nakamura, Kazuhiro, Hamano, Yoshitomo, Ohtsuji, Mareki, Honma, Nakayuki, Serizawa, Isao, Ishii, Yasuyuki, Takiguchi, Masafumi, Hirose, Sachiko, Shirai, Toshikazu
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194093/
https://www.ncbi.nlm.nih.gov/pubmed/12885869
http://dx.doi.org/10.1084/jem.20021301
_version_ 1782147624524054528
author Matsuoka, Shuji
Tsurui, Hiromichi
Abe, Masaaki
Terashima, Kazuo
Nakamura, Kazuhiro
Hamano, Yoshitomo
Ohtsuji, Mareki
Honma, Nakayuki
Serizawa, Isao
Ishii, Yasuyuki
Takiguchi, Masafumi
Hirose, Sachiko
Shirai, Toshikazu
author_facet Matsuoka, Shuji
Tsurui, Hiromichi
Abe, Masaaki
Terashima, Kazuo
Nakamura, Kazuhiro
Hamano, Yoshitomo
Ohtsuji, Mareki
Honma, Nakayuki
Serizawa, Isao
Ishii, Yasuyuki
Takiguchi, Masafumi
Hirose, Sachiko
Shirai, Toshikazu
author_sort Matsuoka, Shuji
collection PubMed
description We earlier found that a rat monoclonal antibody (mAb) RE2 can induce rapid death of murine activated, but not resting, lymphocytes and lymphocyte cell lines, in a complement-independent manner, a cell death differing from typical apoptosis or necrosis. We here found that this cell death is independent of pathways involving Fas, caspase, and phosphoinositide-3 kinase. With the advantage of producing human B cell line transfectants with stable expression of human/mouse xeno-chimeric MHC class I genes, we found that RE2 epitope resides on the murine class I α2 domain. However, the α3 domain plays a key role in transducing the death signal, which mediates extensive aggregation of the MHC class I-integrin-actin filament system, giving rise to membrane blebs and pores. In mouse models with T/NKT cell activation-associated fulminant hepatitis, administration of mAb RE2 almost completely inhibited the development of liver cell injuries. Taken collectively, this form of cell death may be involved in homeostatic immune regulation, and induction of this form of cell death using the mAbs may be potentially therapeutic for subjects with immunological diseases mediated by activated lymphocytes.
format Text
id pubmed-2194093
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21940932008-04-11 A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model Matsuoka, Shuji Tsurui, Hiromichi Abe, Masaaki Terashima, Kazuo Nakamura, Kazuhiro Hamano, Yoshitomo Ohtsuji, Mareki Honma, Nakayuki Serizawa, Isao Ishii, Yasuyuki Takiguchi, Masafumi Hirose, Sachiko Shirai, Toshikazu J Exp Med Brief Definitive Report We earlier found that a rat monoclonal antibody (mAb) RE2 can induce rapid death of murine activated, but not resting, lymphocytes and lymphocyte cell lines, in a complement-independent manner, a cell death differing from typical apoptosis or necrosis. We here found that this cell death is independent of pathways involving Fas, caspase, and phosphoinositide-3 kinase. With the advantage of producing human B cell line transfectants with stable expression of human/mouse xeno-chimeric MHC class I genes, we found that RE2 epitope resides on the murine class I α2 domain. However, the α3 domain plays a key role in transducing the death signal, which mediates extensive aggregation of the MHC class I-integrin-actin filament system, giving rise to membrane blebs and pores. In mouse models with T/NKT cell activation-associated fulminant hepatitis, administration of mAb RE2 almost completely inhibited the development of liver cell injuries. Taken collectively, this form of cell death may be involved in homeostatic immune regulation, and induction of this form of cell death using the mAbs may be potentially therapeutic for subjects with immunological diseases mediated by activated lymphocytes. The Rockefeller University Press 2003-08-04 /pmc/articles/PMC2194093/ /pubmed/12885869 http://dx.doi.org/10.1084/jem.20021301 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Matsuoka, Shuji
Tsurui, Hiromichi
Abe, Masaaki
Terashima, Kazuo
Nakamura, Kazuhiro
Hamano, Yoshitomo
Ohtsuji, Mareki
Honma, Nakayuki
Serizawa, Isao
Ishii, Yasuyuki
Takiguchi, Masafumi
Hirose, Sachiko
Shirai, Toshikazu
A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title_full A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title_fullStr A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title_full_unstemmed A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title_short A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
title_sort monoclonal antibody to the α2 domain of murine major histocompatibility complex class i that specifically kills activated lymphocytes and blocks liver damage in the concanavalin a hepatitis model
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194093/
https://www.ncbi.nlm.nih.gov/pubmed/12885869
http://dx.doi.org/10.1084/jem.20021301
work_keys_str_mv AT matsuokashuji amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT tsuruihiromichi amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT abemasaaki amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT terashimakazuo amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT nakamurakazuhiro amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT hamanoyoshitomo amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT ohtsujimareki amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT honmanakayuki amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT serizawaisao amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT ishiiyasuyuki amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT takiguchimasafumi amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT hirosesachiko amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT shiraitoshikazu amonoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT matsuokashuji monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT tsuruihiromichi monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT abemasaaki monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT terashimakazuo monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT nakamurakazuhiro monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT hamanoyoshitomo monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT ohtsujimareki monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT honmanakayuki monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT serizawaisao monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT ishiiyasuyuki monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT takiguchimasafumi monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT hirosesachiko monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel
AT shiraitoshikazu monoclonalantibodytothea2domainofmurinemajorhistocompatibilitycomplexclassithatspecificallykillsactivatedlymphocytesandblocksliverdamageintheconcanavalinahepatitismodel